T
TOBAM Portfolio holdings
AUM
$256M
This Quarter Return
+11.98%
1 Year Return
+13.59%
3 Year Return
+36.98%
5 Year Return
+80%
10 Year Return
+220.89%
AUM
$1.51B
AUM Growth
+$1.51B
(+5.6%)
Cap. Flow
-$64.1M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
27.14%
Holding
456
New
26
Increased
164
Reduced
144
Closed
50
Top Buys
| 1 |
United Therapeutics
UTHR
|
$18.8M |
| 2 |
Take-Two Interactive
TTWO
|
$14.9M |
| 3 |
Las Vegas Sands
LVS
|
$14M |
| 4 |
Johnson & Johnson
JNJ
|
$12.6M |
| 5 |
Humana
HUM
|
$11.7M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$20M |
| 2 |
Electronic Arts
EA
|
$18.8M |
| 3 |
Franco-Nevada
FNV
|
$13.6M |
| 4 |
Burlington
BURL
|
$12.9M |
| 5 |
Eversource Energy
ES
|
$11.3M |
Sector Composition
| 1 | Healthcare | 33.57% |
| 2 | Consumer Staples | 28.33% |
| 3 | Technology | 7.15% |
| 4 | Communication Services | 6.29% |
| 5 | Materials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$141B
| $46.5M | 3.08% |
906,601
-27,806
| -3% | -$1.42M |
|
2
Merck
MRK
$210B
| $46.2M | 3.06% |
416,066
-61,245
| -13% | -$6.8M |
|
3
General Mills
GIS
$26.4B
| $44.4M | 2.94% |
529,371
+5,231
| +1% | +$439K |
|
4
Kimberly-Clark
KMB
$42.8B
| $42M | 2.78% |
309,506
-22,456
| -7% | -$3.05M |
|
5
Church & Dwight Co
CHD
$22.7B
| $40.2M | 2.66% |
498,685
+30,307
| +6% | +$2.44M |
|
6
Kellanova
K
$27.6B
| $39.8M | 2.63% |
558,191
+35,231
| +7% | +$2.51M |
|
7
J.M. Smucker
SJM
$11.8B
| $39.3M | 2.6% |
248,002
+4,300
| +2% | +$681K |
|
8
Clorox
CLX
$14.5B
| $38M | 2.52% |
270,860
+194
| +0.1% | +$27.2K |
|
9
Campbell Soup
CPB
$9.52B
| $37.5M | 2.48% |
661,340
+7,128
| +1% | +$405K |
|
10
Gen Digital
GEN
$18.6B
| $36.1M | 2.39% |
1,685,760
+66,330
| +4% | +$1.42M |
|
11
Quest Diagnostics
DGX
$20.3B
| $35.8M | 2.37% |
229,043
-30,800
| -12% | -$4.82M |
|
12
Hormel Foods
HRL
$14B
| $35M | 2.32% |
768,456
+17,851
| +2% | +$813K |
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $34.4M | 2.28% |
287,840
+969
| +0.3% | +$116K |
|
14
Dollar Tree
DLTR
$22.8B
| $33.9M | 2.25% |
239,977
+36,172
| +18% | +$5.12M |
|
15
Eli Lilly
LLY
$657B
| $30.5M | 2.02% |
83,445
-8,654
| -9% | -$3.17M |
|
|
16
United Therapeutics
UTHR
$13.8B
| $30.4M | 2.01% |
109,284
+67,767
| +163% | +$18.8M |
|
17
Newmont
NEM
$81.7B
| $29.6M | 1.96% |
626,973
-78,275
| -11% | -$3.69M |
|
|
18
Take-Two Interactive
TTWO
$43B
| $28.3M | 1.87% |
271,462
+143,002
| +111% | +$14.9M |
|
19
C.H. Robinson
CHRW
$15.2B
| $28.2M | 1.87% |
307,718
-16,751
| -5% | -$1.53M |
|
20
AbbVie
ABBV
$372B
| $27.6M | 1.83% |
170,915
+50,459
| +42% | +$8.15M |
|
21
Alnylam Pharmaceuticals
ALNY
$58.5B
| $27.6M | 1.83% |
116,048
+15,183
| +15% | +$3.61M |
|
|
22
Johnson & Johnson
JNJ
$427B
| $25.4M | 1.68% |
143,858
+71,330
| +98% | +$12.6M |
|
23
Schlumberger
SLB
$55B
| $25M | 1.66% |
467,766
+49,287
| +12% | +$2.63M |
|
24
Moderna
MRNA
$9.37B
| $23.8M | 1.58% |
132,726
-18,526
| -12% | -$3.33M |
|
25
Assurant
AIZ
$10.9B
| $23.5M | 1.56% |
187,936
+18,510
| +11% | +$2.31M |
|